None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 19 years or older Body mass index (BMI) = 25 kg/m² Initiating pharmacologic obesity treatment Willing and able to provide informed consent Able to use a continuous glucose monitoring device
Exclusion criteria
Exclusion criteria: Diagnosis of diabetes mellitus or use of glucose-lowering medications Pregnancy or lactation Severe hepatic or renal disease Serious medical or psychiatric conditions that could interfere with study participation Individuals deemed unsuitable for participation by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in body weight and body composition according to CGM-derived glycemic phenotypes | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in metabolic parameters and dietary intake according to CGM-derived glycemic phenotypes | — |
Countries
Korea, Republic of
Contacts
Yonsei University, Wonju Severance Christian Hospital